Literature DB >> 6722416

Cause of death in rheumatoid arthritis.

P Prior, D P Symmons, D L Scott, R Brown, C F Hawkins.   

Abstract

A series of 489 consecutive patients with definite or classical rheumatoid arthritis was followed for a mean of 11.2 years. Cohort-analysis of the series showed a three-fold increase in mortality overall in comparison with age- and sex-specific rates in the general population. In patients first seen in hospital early in the course of the disease (less than 5 years from onset), the excess of deaths from circulatory, respiratory and musculoskeletal disorders was highly significant. Malignant disease and digestive system disorders accounted for a small excess of borderline significance. Patients who were referred later (greater than 5 years from onset) experienced, in addition, a highly significant excess of deaths from infections and disorders of the digestive and genito-urinary system but not from malignant neoplasms.

Entities:  

Mesh:

Year:  1984        PMID: 6722416     DOI: 10.1093/rheumatology/23.2.92

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  60 in total

Review 1.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

2.  Non-Hodgkin's lymphoma in rheumatoid arthritis.

Authors:  D Porter; R Madhok; H Capell
Journal:  Ann Rheum Dis       Date:  1991-05       Impact factor: 19.103

Review 3.  Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review.

Authors:  Taras Gout; Andrew J K Ostör; Muhammad K Nisar
Journal:  Clin Rheumatol       Date:  2011-08-11       Impact factor: 2.980

Review 4.  What should we hope to achieve when treating rheumatoid arthritis?

Authors:  D L Scott; T D Spector; T Pullar; B McConkey
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

Review 5.  Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review.

Authors:  Matthew E Falagas; Katerina G Manta; Gregoria I Betsi; Georgios Pappas
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 2.980

6.  Accounting for cross boundary flows.

Authors:  J Brazier
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-10

7.  Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap.

Authors:  Diane Lacaille; J Antonio Avina-Zubieta; Eric C Sayre; Michal Abrahamowicz
Journal:  Ann Rheum Dis       Date:  2016-12-28       Impact factor: 19.103

8.  Despite increased plasma concentration, inflammation reduces potency of calcium channel antagonists due to lower binding to the rat heart.

Authors:  Saeed Sattari; William F Dryden; Lise A Eliot; Fakhreddin Jamali
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

9.  Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis.

Authors:  R Peltomaa; L Paimela; H Kautiainen; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

10.  Scanning electron microscopy of rheumatoid arthritis peripheral blood polymorphonuclear leucocytes.

Authors:  D A McCarthy; C M Holburn; B K Pell; S R Moore; A P Kirk; J D Perry
Journal:  Ann Rheum Dis       Date:  1986-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.